Back
Madrigal Pharmaceuticals Stock Price Chart
Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.
Sell
47
MDGL
Madrigal Pharmaceuticals
Last Price:
$277.88
Seasonality Move:
-6.38%
7 Day Trial
ALL ACCESS PASS
$
7
Economic Policy Shifts = Huge Market Opportunity
See which of your stocks make the grade - analyze 3 stocks FREE.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing slight selling pressure.
Madrigal Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 275.6 | Buy |
| 20-day SMA: | 281.72 | Sell |
| 50-day SMA: | 302.76 | Sell |
| 200-day SMA: | 293.29 | Sell |
| 8-day EMA: | 277.2 | Buy |
| 20-day EMA: | 283.38 | Sell |
| 50-day EMA: | 297.91 | Sell |
| 200-day EMA: | 294.51 | Sell |
Madrigal Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -8.39 | Sell |
| Relative Strength Index (14 RSI): | 43.62 | Sell |
| Chaikin Money Flow: | -55783 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (273.27 - 298.71) | Sell |
| Bollinger Bands (100): | (292.1 - 339.78) | Sell |
Madrigal Pharmaceuticals Technical Analysis
| May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Madrigal Pharmaceuticals Stock
Is Madrigal Pharmaceuticals Stock a Buy?
-
Madrigal Pharmaceuticals share price is 278.23 while MDGL 8-day simple moving average is 275.60, which is a Buy signal.
-
The stock price of MDGL is 278.23 while Madrigal Pharmaceuticals 20-day SMA is 281.72, which makes it a Sell.
-
Madrigal Pharmaceuticals 50-day simple moving average is 302.76 while MDGL share price is 278.23, making it a Sell technically.
-
MDGL stock price is 278.23 and Madrigal Pharmaceuticals 200-day simple moving average is 293.29, creating a Sell signal.
MDGL Technical Analysis vs Fundamental Analysis
Sell
47
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals a Buy or a Sell?
-
Madrigal Pharmaceuticals stock is rated a SellThe current Madrigal Pharmaceuticals [MDGL] share price is $278.23. The Score for MDGL is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Madrigal Pharmaceuticals Stock Info
Market Cap:
6.2B
Price in USD:
278.23
Share Volume:
279.6K
Madrigal Pharmaceuticals 52-Week Range
52-Week High:
377.46
52-Week Low:
200.63
Sell
47
Madrigal Pharmaceuticals (MDGL)
is a Sell
Madrigal Pharmaceuticals Share Price Forecast
-
What is the Madrigal Pharmaceuticals stock price today?The Madrigal Pharmaceuticals stock price is 278.23 USD today.
-
Will MDGL stock go up or go down?Madrigal Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Madrigal Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Madrigal Pharmaceuticals is overvalued.
Is Madrigal Pharmaceuticals Stock a Buy?
-
Madrigal Pharmaceuticals share price is 278.23 while MDGL 8-day exponential moving average is 277.20, which is a Buy signal.
-
The stock price of MDGL is 278.23 while Madrigal Pharmaceuticals 20-day EMA is 283.38, which makes it a Sell.
-
Madrigal Pharmaceuticals 50-day exponential moving average is 297.91 while MDGL share price is 278.23, making it a Sell technically.
-
MDGL stock price is 278.23 and Madrigal Pharmaceuticals 200-day simple moving average is 294.51, creating a Sell signal.
Fundamental Analysis of Madrigal Pharmaceuticals
Is Madrigal Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $3.44 per share, an increase next quarter of $1.75 per share, an increase this year of $10.60 per share, and an increase next year of $12.26 per share.
Technical Analysis of Madrigal Pharmaceuticals
Should I short Madrigal Pharmaceuticals stock?
-
MDGL Moving Average Covergence Divergence (MACD) indicator is -8.39, suggesting Madrigal Pharmaceuticals is a Sell
-
Madrigal Pharmaceuticals Relative Strength Index (RSI) is 43.62, which suggest Madrigal Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Madrigal Pharmaceuticals is (273.27 - 298.71), which suggest Madrigal Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Madrigal Pharmaceuticals is (292.1 - 339.78), which suggest Madrigal Pharmaceuticals is a Sell
* Madrigal Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.